Stockreport

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF Salt Lake City, Utah, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, [Read more]